Syngene International Limited (BOM:539268)
India · Delayed Price · Currency is INR 592.15
-8.70 (-1.45%)
At close: Jan 22, 2026
Syngene International Employees
Syngene International had 6,533 employees as of March 31, 2025. The number of employees increased by 23 or 0.35% compared to the previous year.
Employees
6,533
Change (1Y)
23
Growth (1Y)
0.35%
Revenue / Employee
5.69M INR
Profits / Employee
538.96K INR
Market Cap
235.91B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 6,533 | 23 | 0.35% |
| Mar 31, 2024 | 6,510 | -337 | -4.92% |
| Mar 31, 2023 | 6,847 | 872 | 14.59% |
| Mar 31, 2022 | 5,975 | 538 | 9.90% |
| Mar 31, 2021 | 5,437 | 491 | 9.93% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Manappuram Finance | 24,650 |
| Force Motors | 4,640 |
| Emami | 3,217 |
| Asahi India Glass | 2,803 |
| Mangalore Refinery and Petrochemicals | 2,530 |
| Deepak Nitrite | 1,757 |
| Timken India | 1,282 |
| NBCC (India) | 1,172 |
Syngene International News
- 5 weeks ago - Syngene International Ltd Webinar on Clinical Trials Market Call Transcript - GuruFocus
- 2 months ago - Syngene International Ltd (BOM:539268) Q2 2026 Earnings Call Highlights: Navigating Growth ... - GuruFocus
- 2 months ago - Q2 2026 Syngene International Ltd Earnings Call Transcript - GuruFocus
- 6 months ago - Goldman Sachs maintains buy on Syngene, bullish on FY26 early-teens growth outlook, sees 15.5% upside on Q1 beat and rising CRO-led margin gains - Business Upturn
- 6 months ago - Syngene Q1 profit up 59% to Rs 87 crore - The Times of India
- 6 months ago - Syngene International Q1 Results: Revenue grows 11% YoY to Rs 790 crore, Net profit jumps 59% YoY - Business Upturn
- 8 months ago - Syngene International receives EIR from USFDA for Biocon Park facility, inspection concludes with VAI classification - Business Upturn
- 9 months ago - Why are Syngene shares down 10% despite Q4 net profit jumping 2.8% YoY? - Business Upturn